iShares China Large-Cap ETF (FXI) › Analysis

iShares China Large-Cap ETF (FXI) analysis, February 26, 2026

Published February 26, 2026 · FXI chart, levels and live analysis

Key Updates

FXI declined 3.28% to $37.42 since the February 12 report, extending the correction from late January highs and now trading at YTD lows (-2.27%). The selloff occurred despite constructive fundamental developments including reduced US tariff expectations (24% vs. 32% previously) and positive MSCI index rebalancing. The divergence between improving fundamentals and price action reflects technical profit-taking after the strong 2025 rally (+18% Shanghai Composite) and regulatory efforts to cool market enthusiasm through the "national team" selling activity. Near-term sentiment remains pressured by post-holiday consumption data scrutiny and spillover from global tech volatility.

Current Trend

FXI is in a short-term correction phase, down 2.27% YTD and 6.31% over one month, breaking below the $39 psychological support established in early February. The ETF has declined 3.08% over five days despite positive catalysts around the Lunar New Year reopening. The broader MSCI China Index gained over 1% during the holiday period, suggesting the FXI weakness is concentrated in large-cap holdings. The $37.42 level represents a critical support zone, with further downside potentially targeting the $36-37 range established in late 2025. Resistance now sits at $39-40, requiring a decisive break above to resume the uptrend that characterized late 2025 and early 2026.

Investment Thesis

The investment thesis for Chinese large-cap equities centers on structural revaluation driven by three factors: technology leadership in AI and robotics positioning China as the second-largest global AI hub; improved US-China trade relations with tariffs declining to 24% from peak levels; and attractive relative valuations with Chinese tech trading at 16x P/E versus higher US multiples. China's strategic pivot toward AI as a national priority, demonstrated through humanoid robot showcases and domestic technology development, supports long-term growth potential. However, the thesis faces near-term headwinds from regulatory intervention to prevent bubble formation, with state-backed investors actively selling to maintain "slow bull" momentum and household equity allocation remaining low at 11% versus 32% in the US.

Thesis Status

The core investment thesis remains intact but faces timing challenges. Fundamental catalysts are materializing as expected—tariff reduction, MSCI additions of 37 Chinese companies (largest since May 2023), and rising institutional allocations with Qube's China fund growing 10-fold to $2 billion. However, Chinese regulators are deliberately tempering the rally through "national team" selling that drove nearly $110 billion in ETF outflows in late January and over 700 billion yuan in outflows last month. This creates a disconnect where improving fundamentals coincide with price weakness. The regulatory approach aims to prevent boom-bust cycles while building sustainable growth, suggesting the thesis will play out over quarters rather than weeks. Deutsche Bank's CIO noting rising equity inflows from Southeast Asia and Europe validates the thesis direction, though execution remains volatile.

Key Drivers

Trade policy developments dominate near-term drivers, with Morgan Stanley projecting average US tariffs on Chinese goods declining to 24% following the Supreme Court ruling on reciprocal tariffs, down from 32% previously. Technology sector momentum continues building, with China positioned as the second-largest global AI hub and leader in robotics and electric vehicles attracting investor attention. Index rebalancing provides structural support, as MSCI added a net 21 Chinese companies in its largest inclusion since May 2023, concentrated in semiconductors, autonomous driving, and quantum information sectors. Regulatory intervention represents a key headwind, with state-backed "national team" actively selling holdings to cool the market after the CSI 300 rose over 20% in the past year. Commodity markets provide supporting context, with copper rising 1.5% to $13,060 per ton on tariff optimism as China's markets reopened.

Technical Analysis

FXI has broken below the $39 support level that held through early February, now testing the $37-38 range with momentum indicators turning negative across all timeframes (1d: -2.60%, 5d: -3.08%, 1m: -6.31%). The ETF is trading at YTD lows despite the Shanghai Composite Index gaining 18% in 2025, indicating underperformance relative to the broader Chinese market. Volume patterns suggest profit-taking rather than capitulation, consistent with the "national team" selling activity. The $37.42 current price sits near the lower end of the recent trading range, with immediate support at $37 and stronger support at $36. Resistance has shifted lower to $38.50-39.00, requiring reclamation of this zone to reverse the downtrend. The five-day decline of 3.08% occurred despite positive holiday reopening expectations, suggesting technical weakness may persist until regulatory selling pressure subsides. RSI and momentum indicators likely approaching oversold territory given the sustained decline, potentially setting up a tactical bounce if fundamental catalysts materialize.

Bull Case

Bear Case

Get a message when the FXI picture changes — the agent team watches the levels and the news for you.Create a free account

More FXI analyses